By Linda A. Johnson

Johnson & Johnson said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.

The affected products, packaged in aerosol cans, are Aveeno Protect + Refresh aerosol sunscreen, and four Neutrogena sunscreen versions: Beach Defense aerosol sunscreen, CoolDry Sport aerosol sunscreen, Invisible Daily Defense aerosol sunscreen and UltraSheer aerosol sunscreen.

The recall includes all can sizes and all levels of sun protection factor, or SPF. The products were distributed nationwide through retailers.

The health care giant said the benzene was found after testing by the company and an independent laboratory. It is investigating how the chemical got into the products.

J&J said it’s working to get all lots of the five products removed from store shelves. It urged consumers to stop using the sunscreens immediately and said customers can get a refund by calling J&J’s Consumer Care Center at 1-800-458-1673. More information is available at the websites for Neutrogena and Aveeno.

J&J said in a statement that “use of these products would not be expected to cause adverse health consequences" and that it voluntarily decided to recall them "out of an abundance of caution.” The statement added that people should use an alternate sunscreen to protect themselves from the skin cancer melanoma.

Benzene is a highly flammable, widely used chemical that's present throughout the environment. It can cause cancer with repeated exposure at high enough levels. It also can damage the immune system and prevent cells from functioning properly, according to the U.S. Centers for Disease Control and Prevention.

The chemical's effects vary by whether a person accidentally inhales or ingests it or gets it on skin and clothing. Symptoms range from dizziness and irregular heartbeat to convulsions and, at very high levels, death.

J&J, which is based in New Brunswick, New Jersey, said it has notified the Food and Drug Administration of the recall.

Share:
More In Business
Elizabeth Holmes Delays Going to Prison With Another Appeal
Disgraced Theranos CEO Elizabeth Holmes has avoided starting her more than 11-year prison sentence on Thursday by deploying the same legal maneuver that enabled her co-conspirator in a blood-testing hoax to remain free for an additional month.
Stretching Your Dollar: Benefits of Cash as an Asset Class
When people think of asset classes, most think of stocks and bonds. Mark Hamrick, senior economic analyst with Bankrate.com, joined Cheddar News to discuss why the current economy is making the cash savings account a more worthwhile investment than it's been in previous years.
Make or Break Week as Strong Tech Results Lift Stocks
Christine Short, vice president of research with Wall Street Horizon, joined Cheddar News to discuss Wednesday's trading session as positive earnings from some tech companies lifted stocks. "This is the safe haven for investors, the barometer of global growth depending on the company we're talking about," she said.
Load More